We believe that the p62 expression in the myo-INIs is more useful in the diagnosis of OPMD as p62 immunohistochemistry is widely used to evaluate RVMs such as IBM, while PABPN1 immunohistochemistry is not. This evidence concerns the gene SQSTM1 and inclusion body myositis.